Home   Site Map   About Roche   Contact Us   Help   
This is a alt text for HepatologyThis is a alt text for Hepatology
Clinical. Credible. Convenient.
Not a Member? Log In Forgot Password? Instant Access Code
Sign Up
»
 E-mail: Password: Code:
  Remember Me Log In
»
 Go
»
Main Menu
Hepatology Home
News
Clinical Trials
Education
Publications
Other Resources
Meeting Calendar

Select a link below to view details.
Previous March 2010 Next
S M T W T F S
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      
Hepatology Clinical Trials

Hepatology Clinical Trials Database
Real-time, comprehensive global Hepatology clinical trials database

  • Global clinical development on a trial-by-trial basis
  • Search by any drug name
  • Search by any status and/or phase of the trial
 TrialTrove™Locked Content Click
Here		  
  What is this?
 
   
 
Roche Clinical Trials
 
Recruiting A study on optimizing HBeAg seroconversion in HBeAg positive CHB patients with combination or sequential treatment of pegalyted interferon alpha-2a and Entecavir
 
 
Recruiting A randomized, open-label study of 2 different treatment durations of PEGASYS plus ribavirin on virological relapse in patients with chronic hepatitis C viral infection, genotype 1 or 4
 
 
Recruiting An open-label study of the safety of PEGASYS alone or in combination with ribavirin in patients with chronic hepatitis C who have participated in previous studies
 
 
Recruiting Randomisierte, partiell doppelt blinde Phase II-Studie zur Untersuchung des Einflusses von RBV auf die virologische Response bei naiven Patienten mit cHC GT-1 mit einer der PEG/RBV Therapie vorgeschalteten 6-wöchigen RBV/Placebo oder PEG-Monotherapie
 
 
Recruiting A follow-up study to evaluate the long-term post treatment effects of peginterferon alfa-2a (PEG-IFN) in patients with HBeAg positive chronic hepatitis B from the original study WV19432(NEPTUNE).
 
 
No longer recruiting A randomized, open-label study to compare the effect of PEGASYS monotherapy and PEGASYS + ribavirin combination therapy on treatment response in patients with chronic hepatitis D.
 
 
No longer recruiting An open-label expanded access study of the efficacy, safety, and tolerability of long-term use of PEGASYS in patients with chronic myelogenous leukemia who have previously participated in PEGASYS study ML16544, NO16006, or ML17228
 
 
No longer recruiting An open-label study to evaluate the effect of PEGASYS® (Peginterferon alfa-2a (40KD)) on the response rate of normal ALT and HDV RNA-negativity in patients with chronic hepatitis D
 
 
No longer recruiting A randomized, open-label study of 2 different treatment durations of PEGASYS with or without lamivudine on ALT and HBV DNA levels/correction in patients with HBeAg-negative chronic hepatitis B infection
 
 
No longer recruiting An open-label study of the effect of PEGASYS on tumor response in patients with chronic myelogenous leukemia, malignant melanoma, or renal cell carcinoma who have responded to treatment with PEGASYS or Roferon-A
 
Clinical Trials Registry and Results
Roche-Trials.com » Visit Roche Trials for more information on completed Roche clinical studies.

ClinicalTrials.gov » ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research in human volunteers.

RocheInvestigators.com » RocheInvestigators.com: Investigators interested in applying to participate in the U.S. arm of global development clinical trials sponsored by Hoffmann-La Roche Inc., please click the link.